GlassScriptPhysician profile
Hugh B Perkin
NPI 1801066063
$10,726.22
in general payments reported to CMS, 2019-2025
50 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $746 · 2021: $768 · 2022: $1,019 · 2023: $3,635 · 2024: $1,374 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,469 · Travel and Lodging: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,468.52 |
| Travel and Lodging | $1,150.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,685.38 | 2023 | Interstim |
| Astellas Pharma US INC | $846.31 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $753.34 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Myriad Genetic Laboratories, INC. | $692.81 | 2020-2025 | Prolaris, Myrisk, Bracanalysis Cdx |
| Sumitomo Pharma America, INC. | $651.21 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $574.15 | 2019-2025 | Provenge |
| Abbvie INC. | $496.41 | 2019-2025 | |
| Pfizer INC. | $453.80 | 2019-2025 | |
| Neotract INC. | $364.57 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $301.60 | 2019-2022 | |
| Procept Biorobotics Corporation | $274.27 | 2023-2025 | Aquabeam Robotic System |
| Boston Scientific Corporation | $268.03 | 2019-2025 | Ams 700 |
| Ferring Pharmaceuticals INC. | $251.90 | 2019-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $191.27 | 2020-2025 | Lynparza |
| Coloplast Corp | $178.82 | 2020-2024 | Titan, Altis, Speedicath |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $175.36 | 2019-2024 | Xiaflex |
| Sun Pharmaceutical Industries INC. | $169.58 | 2021-2025 | |
| Bluewind Medical | $161.10 | 2025 | Revi |
| Teleflex LLC | $153.85 | 2023-2025 | Urolift |
| Foundation Medicine, INC. | $151.24 | 2020-2023 | Foundationone Cdx |
| Urovant Sciences INC | $138.00 | 2022 | |
| Allergan, INC. | $137.59 | 2019-2022 | |
| Antares Pharma, INC. | $133.61 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Medtronic USA, INC. | $121.53 | 2019-2020 | |
| Urogen Pharma, INC. | $102.43 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $101.81 | 2022-2025 | Tlando, Trelstar |
| Bayer Healthcare Pharmaceuticals INC. | $100.24 | 2019-2025 | |
| Biotissue Holdings INC. | $94.19 | 2022 | |
| Accord Healthcare, INC. | $93.71 | 2024-2025 | |
| Axonics, INC. | $77.85 | 2022-2024 | Axonics |
| Therapeuticsmd, INC. | $55.85 | 2019 | |
| Amgen INC. | $55.00 | 2019-2020 | |
| Photocure INC | $54.88 | 2019 | |
| Halozyme INC | $54.77 | 2023 | |
| Myovant Sciences INC. | $52.04 | 2021 | |
| Alnylam Pharmaceuticals INC. | $50.65 | 2024 | Oxlumo |
| Merck Sharp & Dohme LLC | $47.50 | 2020-2024 | Lynparza |
| Clovis Oncology, INC. | $47.17 | 2020 | |
| Metuchen Pharmaceuticals | $46.11 | 2019 | |
| Philips North America LLC | $45.42 | 2022 | |
| Olympus America INC. | $44.82 | 2022-2025 | Itind System |
| Endo USA, INC. | $43.17 | 2024 | Xiaflex, Aveed |
| Tolmar, INC. | $41.25 | 2023 | |
| Blue Earth Diagnostics | $40.47 | 2019-2024 | |
| Travere Therapeutics, INC. | $34.94 | 2019-2021 | |
| Smith+Nephew, INC. | $34.10 | 2023 | Stravix Pl |
| Progenics Pharmaceuticals, INC. | $24.43 | 2024 | |
| Angiodynamics, INC. | $20.85 | 2023 | Nanoknife |
| Baudax Bio INC. | $19.20 | 2020 | |
| Mission Pharmacal Company | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Perkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.